|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.25 TWD | +1.79% |
|
-.--% | - |
| 27/04 | UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 12/08/25 | UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 1.68B 51.94M 45.64M 42.6M 39.1M 73.19M 4.98B 75M 505M 198M 2.46B 195M 191M 8.51B | P/E 2024 |
-9.63x | P/E 2025 | -5.68x |
|---|---|---|---|---|---|
| Enterprise Value | 1.97B 60.86M 53.48M 49.92M 45.81M 85.76M 5.83B 87.87M 592M 231M 2.88B 228M 224M 9.97B | EV / Sales 2024 |
3.58x | EV / Sales 2025 | 3.83x |
| Free-Float |
27.79% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.79% |
| 3 years | 10 |  | 38.5 |
| 5 years | 10 | | 199.22 |
| 10 years | 8.34 | | 288.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jung Kuang Yang
CEO | Chief Executive Officer | - | - |
Meng Han Hsu
DFI | Director of Finance/CFO | - | 11/04/2016 |
Ying Yun Fan
ADM | Chief Administrative Officer | - | 01/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Yun Fan
BRD | Director/Board Member | - | 30/06/2020 |
Yan Ning Kuo
BRD | Director/Board Member | - | 30/06/2020 |
Yao Hui Wei
BRD | Director/Board Member | - | 30/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.79% | -.--% | -.--% | -58.47% | 51.94M | |
| -4.01% | -1.68% | +53.40% | +156.50% | 1,079B | |
| -4.09% | -1.28% | +53.02% | +52.77% | 640B | |
| -3.33% | -0.12% | +35.55% | +71.55% | 465B | |
| -2.35% | +0.92% | +35.86% | +30.34% | 353B | |
| -2.24% | -0.55% | +33.61% | +39.41% | 301B | |
| -2.90% | +0.71% | +11.13% | +14.23% | 271B | |
| -2.08% | +3.09% | +1.60% | -39.53% | 228B | |
| -2.30% | +2.41% | +26.25% | +62.49% | 209B | |
| -3.32% | -1.03% | +12.85% | +70.09% | 165B | |
| Average | -2.40% | +3.06% | +26.33% | +39.94% | 370.97B | |
| Weighted average by Cap. | -3.21% | +1.42% | +38.23% | +74.92% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 539M 16.63M 14.61M 13.64M 12.52M 23.43M 1.59B 24.01M 162M 63.25M 788M 62.43M 61.08M 2.72B | 514M 15.88M 13.95M 13.02M 11.95M 22.37M 1.52B 22.92M 154M 60.38M 752M 59.6M 58.31M 2.6B |
| Net income | -175M -5.39M -4.73M -4.42M -4.05M -7.59M -516M -7.78M -52.38M -20.48M -255M -20.22M -19.78M -882M | -296M -9.14M -8.03M -7.5M -6.88M -12.88M -876M -13.2M -88.93M -34.78M -433M -34.33M -33.58M -1.5B |
| Net Debt | 246M 7.6M 6.68M 6.24M 5.72M 10.71M 728M 10.98M 73.94M 28.92M 360M 28.54M 27.92M 1.25B | 289M 8.92M 7.83M 7.31M 6.71M 12.56M 854M 12.87M 86.71M 33.91M 423M 33.47M 32.75M 1.46B |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- 6562 Stock
Select your edition
All financial news and data tailored to specific country editions
